Stocktoria
Lunai Bioworks Inc. LNAI
Lunai Bioworks Inc. financials (annual)
Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $51,992 | — | — | — | — | — | — | — | — | — |
| R&D expense | $24,518 | $537,428 | $2.7M | $4.2M | $8.4M | $15.7M | $4.7M | $2.5M | $616,961 | $62,763 |
| Operating income | -$8.7M | -$189.0M | -$81.6M | -$38.6M | -$116.1M | -$23.4M | -$11.9M | -$11.0M | -$5.3M | -$2.4M |
| Interest expense | — | — | — | — | $372,844 | $379,608 | $104,280 | $43 | $143,262 | — |
| Income tax | $1,406 | $1,474 | $0 | — | $34 | -$125,276 | — | — | -$111,716 | -$64,877 |
| Net income | -$3.6M | -$178.0M | -$88.4M | -$39.7M | -$113.4M | -$26.7M | -$11.4M | -$18.0M | -$6.3M | -$2.1M |
| EPS (diluted) | $-1.06 | $-86.27 | $-0.91 | $-0.71 | $-2.16 | — | — | — | — | — |
| Operating cash flow | -$5.3M | -$7.9M | -$11.0M | -$11.8M | -$15.7M | -$20.6M | -$10.5M | -$8.5M | -$4.3M | -$1.2M |
| Free cash flow | -$5.3M | — | -$11.0M | -$11.8M | -$15.7M | -$20.7M | -$10.6M | -$9.2M | -$4.4M | — |
| Cash & equivalents | $1.7M | $92,700 | $220,467 | $1.9M | $9.2M | $20.7M | $8.7M | $12.3M | $15.6M | $3.9M |
| Total assets | $9.9M | $8.2M | $163.1M | $58.3M | $84.6M | $189.6M | $178.1M | $179.9M | $182.5M | $4.5M |
| Total liabilities | $19.0M | $29.6M | $31.2M | $11.8M | $12.0M | $14.9M | $11.8M | $6.8M | $23.8M | $3.0M |
| Shareholders' equity | -$9.0M | -$21.3M | $132.0M | $46.5M | $72.6M | $174.7M | $166.3M | $173.1M | $158.7M | $1.5M |
Computed from company filings · US · as of 2026-06-30. Facts plus Stocktoria's own computed scores — not investment advice.